Target intelligence / Profile preview

Respiratory syncytial virus attachment glycoprotein (G protein) (RSV G protein)

Target
RSV G protein
Molecular classification
Viral glycoprotein, Attachment protein, Mucin-like protein, Transmembrane protein
01

Overview

The respiratory syncytial virus attachment glycoprotein (G protein) is a heavily glycosylated 95 kDa viral surface protein essential for RSV pathogenesis and infectivity. As the primary attachment protein of RSV, the G protein binds to host cell receptors including heparan sulfate proteoglycans and other molecules on the surface of ciliated airway epithelial cells, initiating the early stages of viral infection. Unlike the highly conserved fusion (F) protein, the RSV G protein is remarkably variable between viral isolates, with extensive sequence divergence in its mucin-like domains that makes it a useful marker for studying viral evolution and distinguishing between RSV A and B subtypes. Beyond its role in viral attachment, the G protein actively modulates host immune responses and promotes viral evasion of the innate immune system, contributing significantly to disease pathogenesis. Both the G and F glycoproteins are major targets for neutralizing antibodies following natural infection, making them attractive candidates for vaccine development. The G protein's antigenic properties and its critical role in the infection process make it an important target for therapeutic interventions, though its high variability presents challenges for the development of broadly effective treatments across different RSV strains.

Other names
Attachment glycoproteinG glycoproteinRSV GViral attachment protein
02

Mechanism of action

The G protein functions through the following mechanism: 1. Recognition and binding: The G protein recognizes and binds to specific receptors on the host cell surface, including heparan sulfate proteoglycans 2. Attachment initiation: G initiates virion attachment to the host cell 3. Immune evasion: The G protein actively evades host immune responses through antigenic variation

03

Biological functions

Viral attachment: The RSV G protein is the primary attachment protein of the virus that binds to host cell receptors, initiating the infection processCell targeting: G targets the ciliated cells of the airwaysImmune modulation: The G protein induces, modifies, and evades host immune responses to promote RSV infectionHost cell interaction: G protein interacts with host cell surface molecules including heparan sulfate proteoglycans (HSPGs), Surfactant Protein A (SP-A), and Annexin II
04

Disease associations

Infection: Respiratory syncytial virus infection. The G protein plays a key role in RSV infection and contributes to disease pathogenesis
05

Safety considerations

Antigenic variability: The G protein's high variability between RSV isolates presents a challenge for vaccine and therapeutic development, as it may affect efficacy across different viral strainsImmune evasion: The G protein actively modulates and evades host immune responses, which may require careful design of therapeutics to overcome this mechanismPotential for resistance: The variability of the G protein suggests potential for rapid emergence of escape variants if therapeutic pressure is applied
06

Biomarkers

Antigenic variation: The G protein's high sequence variability serves as a biomarker for RSV strain differentiation and evolution trackingSubtype distinction: The G protein is closely related to the determination of antigenic epitopes and the diversity of viral genes, playing a significant role in distinguishing between RSV A and B subtypesNeutralizing antibody response: The presence of anti-G neutralizing antibodies can serve as a biomarker of infection and immune response

Beyond the preview

Go deeper on Respiratory syncytial virus attachment glycoprotein (G protein) (RSV G protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Respiratory syncytial virus attachment glycoprotein (G protein) (RSV G protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call